Pfizer Inc (PFE)
Quick ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Cash | US$ in thousands | 1,043,000 | 2,853,000 | 416,000 | 1,944,000 | 1,784,000 |
| Short-term investments | US$ in thousands | 19,434,000 | 9,837,000 | 22,316,000 | 29,125,000 | 10,437,000 |
| Receivables | US$ in thousands | — | — | — | — | — |
| Total current liabilities | US$ in thousands | 42,995,000 | 47,794,000 | 42,138,000 | 42,671,000 | 25,920,000 |
| Quick ratio | 0.48 | 0.27 | 0.54 | 0.73 | 0.47 |
December 31, 2024 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($1,043,000K
+ $19,434,000K
+ $—K)
÷ $42,995,000K
= 0.48
The quick ratio of Pfizer Inc has displayed fluctuations over the years as follows:
- December 31, 2020: 0.47
- December 31, 2021: 0.73
- December 31, 2022: 0.54
- December 31, 2023: 0.27
- December 31, 2024: 0.48
The quick ratio measures the company's ability to meet its short-term obligations with its most liquid assets. A quick ratio below 1 indicates that the company may have difficulty meeting its short-term liabilities. Pfizer's quick ratio has varied, showing some improvement in 2021 but dropping significantly in 2023, before recovering in 2024. Overall, the company may need to carefully manage its liquidity to ensure it can meet its short-term obligations effectively.
Peer comparison
Dec 31, 2024